Update information
October 2018: The recommendations and section 2 were updated because the marketing authorisation for romiplostim now includes people who have not had a splenectomy.
May 2014: The recommendation wording was updated in line with NICE's existing wording conventions and the wording used in NICE's technology appraisal guidance on eltrombopag for treating chronic immune thrombocytopenia.
Minor changes since publication
January 2023:The title of this guidance was updated and the term 'immune (idiopathic) thrombocytopenic purpura' was changed to 'immune thrombocytopenia' throughout.
ISBN: 978-1-4731-3151-4